88 results on '"Kastelein, John J.P."'
Search Results
2. Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials
3. Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinic
4. A meta-analysis of medications directed against PCSK9 in familial hypercholesterolemia
5. LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial
6. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia
7. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
8. Targeted exonic sequencing of GWAS loci in the high extremes of the plasma lipids distribution
9. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia
10. Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS
11. Familial hypercholesterolaemia: A global call to arms
12. Screening and treatment of familial hypercholesterolemia – Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014)
13. Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood
14. Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia
15. Low plasma adiponectin exacerbates the risk of premature coronary artery disease in familial hypercholesterolemia
16. C-reactive protein and atherogenesis: From fatty streak to clinical event
17. Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes
18. Adeno-associated virus LPL S447X gene therapy in LDL receptor knockout mice
19. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: The EPIC-Norfolk prospective population study 1993–2003
20. Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent–offspring study
21. PON 2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients
22. Parental history of myocardial infarction: lipid traits, gene polymorphisms and lifestyle
23. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertrygliceridemia
24. Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia
25. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia
26. Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease
27. siRNA to PCSK9 in patients with high cardiovascular risk and elevated LDL-C: the ORION 1 trial
28. Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology
29. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers
30. Statin therapy and secretory phospholipase A2 in children with heterozygous familial hypercholesterolemia
31. High-dose statin monotherapy versus low-dose statin/ezetimibe combination on fasting and postprandial lipids and endothelial function in obese patients with the metabolic syndrome: The PANACEA study
32. Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness
33. Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality
34. ABCA1 impacts athero-thrombotic risk and 10-year survival in a contemporary secondary prevention setting
35. Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT
36. The metabolism of triglyceride-rich lipoproteins revisited: New players, new insight
37. Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis
38. Physical activity, the Framingham risk score and risk of coronary heart disease in men and women of the EPIC-Norfolk study
39. Reduced fecal sterol excretion in subjects with familial hypoalphalipoproteinemia
40. HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study
41. 5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia
42. Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease
43. ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia
44. Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia
45. Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors
46. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants
47. Adeno-associated virus LPLS447X gene therapy in LDL receptor knockout mice
48. The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia
49. A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies
50. Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.